Clinical Trials Browser

Phase EARLY_PHASE1 × alpha-2'-deoxythioguanosine × 90 days × Clear all

NCT07446257 2026-03-03

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular